The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valerie Daggett spoke… Read More
Nortis, a Seattle-area startup founded in 2011 that markets “organ-on-a-chip” technology, has raised $6 million, according to an SEC filing. The company’s microfluidic chips foster the growth of human cells… Read More
A Seattle-area startup called Pattern Computer is developing a rapid COVID-19 test based on patterns in light from spit, one of several projects moving ahead from the 7-year-old company that designed its… Read More
EMulate Therapeutics, a 20-year-old Bellevue, Wash.-based company developing radio frequency energy technology to treat a range of diseases, filed to go public Tuesday. The 7-person company, previously known as Nativis,… Read More
The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to disease and… Read More
A new regulatory filing details Amazon’s behind-the-scenes talks for One Medical, leading up to the Seattle tech giant’s agreement to acquire the primary care company for $3.9 billion, announced by… Read More
Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a nearly $1.8 million grant from the U.S. Army. “We hope… Read More
Vancouver, Wash.-based drug design and development company Absci laid off employees Tuesday, a little more than a year after going public. “The macro-economic conditions of the last few months prompted… Read More
Seattle startup SEngine Precision Medicine has raised $10 million to propel drug discovery and development and advance its test that tailors drugs to cancer patients. SEngine cultures patient cancer cells… Read More
Anthony Fauci, President Biden’s chief medical advisor and a leader of the country’s COVID-19 response, made a pit stop in Seattle for a fireside chat at Fred Hutchinson Cancer Center… Read More
Will consumers order up healthcare through Amazon Prime as easily as they stream The Boys or buy an Echo speaker? That’s one question raised by Amazon’s planned $3.9 billion acquisition… Read More
Seagen reported second quarter revenue of $498 million, up 28%, beating analyst expectations. The company also recently reported “positive” early data from a trial testing its drug Padcev in combination… Read More
The news: Single cell analysis startup Ozette Technologies, with deep roots in the Seattle academic and startup community, has raised $26 million. The company’s tools enable its academic and biopharma… Read More
A quiet Seattle biotech company, Intrinsic Medicine, filed to go public in April but withdrew its plans yesterday, according to a regulatory filing. Intrinsic Medicine is developing sugar-based molecules matching… Read More
Seattle area biotech company Seagen released early data on a trial of its drug Padcev combined with Merck’s Keytruda in patients with certain types of urothelial cancer. An analyst with… Read More
Frazier Healthcare Partners’ SPAC has found a partner. The venture firm inked a deal to bring Dutch biotech company NewAmsterdam Pharma public through a merger with its blank check company… Read More
Amazon’s planned $3.9 billion acquisition of One Medical will bring Amazon further into healthcare. But whether the Seattle tech giant will upend the medical system in the same way the company… Read More
Less than two years after its IPO and months after shutting down its once-promising oncology program, Seattle-based Silverback Therapeutics will merge with another biotech company, San Diego-based ARS Pharmaceuticals. The… Read More
Amazon announced a deal to acquire publicly traded primary care company One Medical for $3.9 billion, further fueling the Seattle-based tech giant’s ambitions in healthcare. The all-cash deal would be… Read More
— Mark Simms, a former longtime Microsoft engineering leader, has joined Twilio as chief technology officer. Simms spent 14 years at Microsoft, most recently as director of architecture in the… Read More
The Bill & Melinda Gates Foundation says it will increase its annual payout in grants and other financial assistance by 50% to $9 billion by 2026, responding to what it… Read More
Fred Hutchinson Cancer Center is leveraging Amazon’s machine learning expertise to collaborate on an early-stage clinical trial testing an anti-cancer vaccine in patients with certain types of breast cancer or… Read More
The Institute for Protein Design is an innovation factory. Since launching a decade ago, the University of Washington institution has grown to about 200 researchers and spun out eight startups… Read More
A new Wall Street Journal report revealed that Merck is in “advanced talks” to acquire Seattle-area biotech giant Seagen in a deal that could be worth $40 billion or more.… Read More
Two COVID-19 vaccines developed in Seattle got the nod from regulatory agencies outside the U.S. this week. A University of Washington shot is ready for rollout in South Korea, and… Read More
A new startup aims to change how food is preserved and stored, using tech that keeps meat, fish and produce flavorful at subzero temperatures. “More than a third of the… Read More
ARCH Venture Partners has closed a $2.975 billion fund targeted for early-stage biotech companies. The firm’s 12th venture fund comes on the heels of a nearly $2 billion fund announced… Read More
Two COVID-19 vaccines with roots in Seattle cleared major regulatory milestones Wednesday. South Korea approved a shot developed by University of Washington researchers and Indian regulatory authorities issued an emergency… Read More
Three Seattle biotech companies are joining forces to support open-access development of protein folding and design software. The project, called OpenFold, brings together Cyrus Biotechnology, Outpace Bio, and Arzeda, startups… Read More
A University of Washington program to support STEM students from low-income and underserved backgrounds is now nine years old. And it aims to spread the model to other institutions. The… Read More
